Skip to main content

Julie Hambleton

Equibles does not estimate personal net worth.

Get an email with a short summary when Erasca, Inc. publishes a filing, an earnings call transcript or a press release.

Get ERAS alerts

About Julie Hambleton

Julie Hambleton is recorded as Board Member at Erasca, Inc. (ERAS). The newest filing on record that lists Julie Hambleton as Board Member at Erasca, Inc. (ERAS) is dated April 28, 2026. The proxy statement of IDEAYA Biosciences, Inc. reports total compensation of $686,726 for Julie Hambleton in fiscal 2019, including a base salary of $387,063. Disclosed compensation is on record for 2 fiscal years. Erasca, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Erasca, Inc. includes Jonathan Lim (CEO), David Chacko (CFO), Ebun S. Garner (General Counsel) and 7 others.

Affiliation history

Company network

Current role

Biotechnology · Healthcare

Board Member

Leadership on record at Erasca, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2019 IDEAYA Biosciences, Inc. (IDYA) $387,063 $686,726
2018 IDEAYA Biosciences, Inc. (IDYA) $218,750 $797,642

Recent activity

No call appearances or filed executive changes recorded yet.